Views on Dishman Pharamaceuticals 4QFY2014 results - Angel Broking

Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking) on Dishman Pharamaceuticals 4QFY2014 results:

"Dishman Pharmaceuticals, posted results better than expected, on all fronts. On sales, the company posted a top-line growth of 15.9% to Rs. 400.6cr V/s Rs. 359cr expected. The growth was driven by the CRAMS, posting a yoy growth of 24.6%.The OPM, came in at 21.9% V/s 19.4%, and 21.8% in 4QFY2013.This aided the net profit to come in at Rs. 22.6cr V/s Rs. 17cr expected, a yoy growth of 21.6%. Currently, we have a buy with a target price of Rs. 116."

Dishman Pharmaceuticals (CMP: Rs. 88/ TP: - Rs. 116/ Upside: 31.8)

Shares of DISHMAN PHARMACEUTICALS & CHEMICALS LTD. was last trading in BSE at Rs.104.45 as compared to the previous close of Rs. 104. The total number of shares traded during the day was 436834 in over 7210 trades.

The stock hit an intraday high of Rs. 106.4 and intraday low of 101.5. The net turnover during the day was Rs. 45580099.

Source : Equity Bulls

Keywords